Interview with David A. Rudnick, M.D., Ph.D

Antifibrotic Therapies in Liver Disease: Ready for Primetime?

Clinical Liver Disease (CLD), an official digital learning resource of The American Association for the Study of Liver Diseases is an interactive, up-to-date source of education, designed for physicians and healthcare providers caring for the patient with liver disease. CLD provides current and clinically relevant information through educational interventions every two months.

Share Antifibrotic Therapies in Liver Disease: Ready for Primetime?

Sign up to save your podcasts

Antifibrotic Therapies in Liver Disease: Ready for Primetime?

Antifibrotic Therapies in Liver Disease: Ready for Primetime?